Sofinnova Ventures' New $440M Eighth Fund Exceeds Expectations And Makes Adjustments
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm wins higher commitments from limited partners, turning its health-care focus to late stage companies and forgoing high-tech investments.